Adverum Biotechnologies Inc (NASDAQ:ADVM)
| 0.893 Delayed Data As of May 27 |  +0.0191 / +2.19%Today’s Change | 0.80 Today|||52-Week Range 3.86 | -49.26% Year-to-Date |
Latest ADVM News | Press Releases
No recent news for Adverum Biotechnologies Inc.
Today’s Trading
| Previous close | 0.87 |
| Today’s open | 0.88 |
| Day’s range | 0.87 - 0.90 |
| Volume | 6,482 |
| Average volume (3 months) | 1,003,348 |
| Market cap | $84.0M |
Data as of 3:59pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -7.56% |
| Earnings growth (this year) | +2.87% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 23.01 |
| Price/Book | 0.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OTLCOncotelic Therapeuti... | +0.00 | +1.09% |
| --Adocia SA | 0.00 | 0.00% |
| EQEquillium Inc | +0.03 | +1.21% |
| APTOAptose Biosciences I... | -0.01 | -1.51% |
Data as of 4:00pm ET, 05/27/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $7.5M |
| Annual profit (last year) | -$145.5M |
| Net profit margin | -1,940.53% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
